Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potentialHubert Krukowski, Griet Glorieux, Sophie Valkenburg et al.|Nature Reviews Nephrology|2022Cited by 112
Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney DiseaseMieke Steenbeke, Griet Glorieux, Sophie Valkenburg et al.|Toxins|2021Cited by 32
Uremic Toxins and Cardiovascular SystemSophie Valkenburg, Raymond Vanholder, Griet Glorieux|Cardiology Clinics|2021Cited by 22
Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKDSonnal Lohia, Antonia Vlahou, Sophie Valkenburg et al.|Heliyon|2024Cited by 5
Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney DiseaseEmmanouil Mavrogeorgis, Joachim Jankowski, Sophie Valkenburg et al.|Proteomes|2024Cited by 1